Sensex

Nifty

USDINR

GBPINR

EURINR

Thursday, 24 October 2024 10:35 AM	Adani-Ports1352.40	Asian-Paints2990.00	Axis-Bank1162.95	Bajaj-Finance7036.75	Bajaj-Finserv1728.60	Bharti-Airtel1665.00	HCL-Technologies1837.85	HDFC-Bank1761.50	Hind-Unilever2491.65	ICICI-Bank1257.25	IndusInd-Bank1276.35	Infosys1865.55	ITC476.15	JSW-Steel958.25	Kotak-Mah-Bank1763.05	Larsen-and-Toubro3455.50	M-and-M2796.00	Maruti-Suzuki11819.70	Nestle-India2273.40	NTPC414.80	Power-Grid-Corpn320.50	Reliance-Industr2665.90	St-Bk-of-India795.35	Sun-PharmaInds1849.45	Tata-Motors886.05	Tata-Steel149.70	TCS4032.30	Tech-Mahindra1734.65	Titan-Company3318.25	UltraTech-Cem10952.90
15 mins delay SENSEX 80,103.30 [21.32]	11.95 0.89%	-0.65 -0.02%	2.45 0.21%	39.40 0.56%	-11.35 -0.65%	-20.00 -1.19%	-8.15 -0.44%	25.80 1.49%	-166.35 -6.26%	5.70 0.46%	4.20 0.33%	-7.30 -0.39%	-4.40 -0.92%	3.75 0.39%	-2.80 -0.16%	0.15 0.00%	5.50 0.20%	-143.45 -1.20%	-53.70 -2.31%	6.55 1.60%	3.70 1.17%	-11.80 -0.44%	9.40 1.20%	11.35 0.62%	8.80 1.00%	0.90 0.60%	-34.45 -0.85%	-0.25 -0.01%	28.40 0.86%	200.70 1.87%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Zydus Life rises on USFDA nod for heart failure drug

10-Jul-24 15:36Hrs IST

Sacubitril and Valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and hospitalization. The said drug is equivalent to reference listed drug, Entresto tablets.

The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India), said the firm.

The group now has 399 approvals and has so far filed over 460 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The pharma major reported consolidated net profit of Rs 1,182.3 crore in Q4 FY24 steeply higher than Rs 296.6 crore recorded in Q4 FY23. Revenue from operations jumped 10.44% to Rs 5,533.8 crore during the quarter as compared with Rs 5,010.6 crore posted in corresponding quarter last year.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise